Conexiant
Login
  • Corneal Physician
  • Glaucoma Physician
  • New Retinal Physician
  • Ophthalmology Management
  • Ophthalmic Professional
  • Presbyopia Physician
  • Retinal Physician
The Ophthalmologist
  • Explore

    Explore

    • Latest
    • Insights
    • Case Studies
    • Opinion & Personal Narratives
    • Research & Innovations
    • Product Profiles

    Featured Topics

    • Anterior Segment
    • Glaucoma
    • Retina

    Issues

    • Latest Issue
    • Archive
  • Subspecialties
    • Cataract
    • Cornea
    • Glaucoma
    • Neuro-ophthalmology
    • Oculoplastics
    • Pediatric
    • Retina
  • Business

    Business & Profession

    • Professional Development
    • Business and Entrepreneurship
    • Practice Management
    • Health Economics & Policy
  • Training & Education

    Career Development

    • Professional Development
    • Career Pathways

    Events

    • Webinars
    • Live Events
  • Events
    • Live Events
    • Webinars
  • Community

    People & Profiles

    • Power List
    • Voices in the Community
    • Authors & Contributors
  • Multimedia
    • Video
    • Podcasts
Subscribe
Subscribe

False

Advertisement
The Ophthalmologist / Case Studies / Uncovering Ocular Comorbidity
Research & Innovations Research & Innovations Cornea Anterior Segment Cataract

Uncovering Ocular Comorbidity

Using InflammaDry<sup>®</sup> to diagnose pre-existing dry eye prior to refractive cataract surgery

Quidel 9/11/2020 0 min read

Share

williamson-CS-Headshot.png

Blake K. Williamson is a third-generation ophthalmologist at The Williamson Eye Center in Baton Rouge, LA, USA. He specializes in laser assisted cataract surgery with advanced IOLs and modern laser vision correction.

When considering InflammaDry® (Quidel Corporation, San Diego, CA, USA) – the first commercially available, rapid result, in-office test that detects elevated levels of inflammatory marker MMP-9 – surgeons typically want an answer to a simple question: “How will MMP-9 testing change what I do?”

For Williamson, the role of MMP-9 testing is crucial – a positive test result indicates the need for pulsed steroids, preservative-free artificial tears, and cyclosporin. In short, MMP-9 positive equals steroids.

Background

The patient is a healthy 60-year-old attorney who came to the clinic to discuss cataract surgery. She complained of tired eyes after long hours at work, but had no other ocular comorbidities. The patient desired freedom from bifocals and wanted to be able to see at distance without glasses. She was content to use reading glasses.

Diagnosis

As part of our workup for all cataract surgeries, the patient received both osmolarity and MMP-9 testing, revealing the following:

  • Positive MMP-9, indicating dry eye disease

  • Mild cornea staining with trace inferior SPK

  • Ocular surface disease revealed by corneal topography (see Figure 1)

  • 2D irregular astigmatism at an axis of 6 degrees

williamson-CS-fig1.png

Intervention and treatment

A toric lens was considered, but ruled out due to concerns about how much of the patient’s irregular cylinder was due to ocular surface changes. The patient was put on a four-week course of loteprednol and cyclosporine, as well as preservative-free artificial tears.

The role of MMP-9

When a patient is MMP-9 positive, both the magnitude and meridian of astigmatism will likely change from pre-op to post-ocular surface optimization, when the patient is ready for phacoemulsification.

Clearly, MMP-9 testing is important – even in patients without dry eye symptoms, as many dry eye patients can be asymptomatic. In this patient case, if I had trusted the original topography, her astigmatism would have been overcorrected on the incorrect axis, and she would have been left with residual refractive error. And I would have been left with an unhappy patient.

Patient outcome

After the four-week treatment plan, astigmatism had been reduced to 0.85 D at an axis of 66. Several serial topographies confirmed astigmatic stability, and the patient underwent successful femtosecond laser-assisted cataract surgery with a monofocal lens.

This case demonstrates the importance of optimizing the ocular surface prior to refractive cataract surgery. The patient now enjoys 20/20 uncorrected distance vision.

www.quideleyehealth.com

Download the Case Study as a pdf

View all InflammaDry® cases studies

Related Content

Omics
Turning Tides

January 9, 2024

3 min read

A new study shows evidence for sustained human-to-human transmission of mpox since 2016

“Pop” Goes the Sensor
Omics
“Pop” Goes the Sensor

January 19, 2022

1 min read

A new device could help scientists identify signs of arrhythmia, heart attack, and cardiac fibrosis

Improving Risk Stratification
Omics
Improving Risk Stratification

February 3, 2022

1 min read

Two genes have been identified that may be linked to prostate cancer outcomes

The Ultimate Vision for Rare Disease
Omics
The Ultimate Vision for Rare Disease

February 28, 2022

1 min read

Genomics and computational Ophthalmology can take rare disease diagnostics to the next level

Newsletters

Receive the latest Ophthalmology news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

False

Advertisement

Explore More in Ophthalmology

Dive deeper into the world of Ophthalmology. Explore the latest articles, case studies, expert insights, and groundbreaking research.

False

Advertisement
The Ophthalmologist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2025 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.

Disclaimer

The Ophthalmologist website is intended solely for the eyes of healthcare professionals. Please confirm below: